The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6
Open accessAbstract
We present a simple and safe strategy for producing high-titer adeno-associated virus (AAV) vectors derived from six different AAV serotypes (AAV-1 to AAV-6). The method, referred to as "HOT," is helper virus free, optically controllable, and based on transfection of only two plasmids, i.e., an AAV vector construct and one of six novel AAV helper plasmids. The latter were engineered to carry AAV serotype rep and cap genes together with adenoviral helper functions, as well as unique fluorescent protein expression cassettes, allowing confirmation of successful transfection and identification of the transfected plasmid. Cross-packaging of vector DNA derived from AAV-2, -3, or -6 was up to 10-fold more efficient using our novel plasmids, compared to a conservative adenovirus-dependent method. We also identified a variety of useful antibodies, allowing detection of Rep or VP proteins, or assembled capsids, of all six AAV serotypes. Finally, we describe unique cell tropisms and kinetics of transgene expression for AAV serotype vectors in primary or transformed cells from four different species. In sum, the HOT strategy and the antibodies presented here, together with the reported findings, should facilitate and support the further development of AAV serotype vectors as powerful new tools for human gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For the majority of rAAV vectors, the ITRs and rep gene of serotype 2 (AAV2) are utilized resulting in pseudo-typed rAAVs [11].”
From Understanding Capsid Assembly and Genome Packaging for Adeno-Associated Viruses (2017) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,409
Zolotukhin, S., Byrne, B. J., Mason, E. G., Zolotukhin, I., Potter, M., Chesnut, K. A., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,321
Kay, M. A., Manno, C. S., Ragni, M. V., Larson, P. J., Couto, L. B., McClelland, A., Glader, B. E., Chew, A. K., Tai, S. J., Herzog, R. W., et al. (2000) · Nature Genetics · doi:10.1038/73464 · Cited by 1,019
Self-citationRabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., & Samulski, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.791-801.2002 · Cited by 762
Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors
Grimm, D., Kern, A., Rittner, K., & Kleinschmidt, J. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2745 · Cited by 701
Self-citationA "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells
Zolotukhin, S., Potter, M., Hauswirth, W. W., Guy, J., & Muzyczka, N. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4646-4654.1996 · Cited by 609
Gene therapy vectors based on adeno-associated virus type 1
Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3994-4003.1999 · Cited by 541
Davidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., & Chiorini, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3428 · Cited by 531
Current protocols in human genetics
Bates, G. P. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89147-7 · Cited by 484
Cited by
Sorted by citations
Items 101–200 of 344
Mietzsch, M., Casteleyn, V., Weger, S., Zolotukhin, S., & Heilbronn, R. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.050 · Cited by 65
Blits, B., Derks, S., Twisk, J., Ehlert, E., Prins, J., & Verhaagen, J. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.10.009 · Cited by 66
Dondzillo, A., Sätzler, K., Horstmann, H., Altrock, W., Gundelfinger, E., & Kuner, T. (2010) · The Journal of comparative neurology · doi:10.1002/cne.22260 · Cited by 72
Adriaansen, J., Vervoordeldonk, M. J., & Tak, P. P. (2006) · Rheumatology · doi:10.1093/rheumatology/kel047 · Cited by 68
PIAS2-mediated blockade of IFN-β signaling: a basis for sporadic Parkinson disease dementia
Magalhães, J., Tresse, E., Ejlerskov, P., Hu, E., Liu, Y., Marín, A., Montalant, A., Satriano, L., Rundsten, C. F., Carlsen, E. M., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01207-w · Cited by 65
Kuck, D., Lau, T., Leuchs, B., Kern, A., Müller, M., Gissmann, L., & Kleinschmidt, J. A. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.2621-2630.2006 · Cited by 66
Self-citationMyelin Basic Protein Cleaves Cell Adhesion Molecule L1 and Promotes Neuritogenesis and Cell Survival
Lutz, D., Loers, G., KLEENE, R. B., Oezen, I., Kataria, H., Katagihallimath, N., Braren, I., Harauz, G., & Schachner, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.530238 · Cited by 63
Langou, K., Moumen, A., Pellegrino, C., Aebischer, J., Medina, I., Aebischer, P., & Raoul, C. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06806.x · Cited by 64
Homeostatic Plasticity Shapes Cell-Type-Specific Wiring in the Retina
Tien, N.-W., Soto, F., & Kerschensteiner, D. (2017) · Neuron · doi:10.1016/j.neuron.2017.04.016 · Cited by 65
Adriaansen, J., Tas, S. W., Klarenbeek, P. L., Bakker, A. C., Apparailly, F., Firestein, G. S., Jørgensen, C., Vervoordeldonk, M. J., & Tak, P. P. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.035063 · Cited by 62
Progress in the Use of Adeno-Associated Viral Vectors for Gene Therapy
Büning, H., Braun‐Falco, M., & Hallek, M. J. (2004) · Cells Tissues Organs · doi:10.1159/000079988 · Cited by 62
Dusonchet, J., Bensadoun, J., Schneider, B. L., & Aebischer, P. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.03.013 · Cited by 61
Experience‐induced plasticity of thalamocortical axons in both juveniles and adults
Wimmer, V. C., Broser, P. J., Kuner, T., & Bruno, R. M. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22483 · Cited by 62
Ren, R., Li, Y., Liu, Z., Liu, K., & He, S. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8484 · Cited by 60
Ciron, C., Cressant, A., Roux, F., Raoul, S., Chérel, Y., Hantraye, P., Déglon, N., Schwartz, B., Barkats, M., Heard, J., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2008.155 · Cited by 60
Corneal Gene Therapy: Basic Science and Translational Perspective
Mohan, R. R., Rodier, J. T., & Sharma, A. (2013) · The Ocular Surface · doi:10.1016/j.jtos.2012.10.004 · Cited by 61
Advancements in the design and scalable production of viral gene transfer vectors
Sharon, D. M., & Kamen, A. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26461 · Cited by 66
Combinatorial Expression of α- and γ-Protocadherins Alters Their Presenilin-Dependent Processing
Bonn, S., Seeburg, P. H., & Schwarz, M. K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01708-06 · Cited by 55
Towne, C. L., Setola, V., Schneider, B. L., & Aebischer, P. (2010) · Molecular Therapy · doi:10.1038/mt.2010.260 · Cited by 59
Große, S., Penaud‐Budloo, M., Herrmann, A.-K., Börner, K., Fakhiri, J., Laketa, V., Krämer, C., Wiedtke, E., Gunkel, M., Ménard, L., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01198-17 · Cited by 62
Self-citationFakhiri, J., Schneider, M. A., Puschhof, J., Stanifer, M. L., Schildgen, V., Holderbach, S., Voß, Y., Andari, J. E., Schildgen, O., Boulant, S., et al. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.01.003 · Cited by 58
Self-citationScalable production of adeno‐associated virus type 2 vectors via suspension transfection
Park, J. Y., Lim, B., Lee, K., Kim, Y. K., & Jo, E. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.20776 · Cited by 55
A User's Guide to the Inverted Terminal Repeats of Adeno-Associated Virus
Wilmott, P., Lisowski, L., Alexander, I. E., & Logan, G. J. (2019) · Human Gene Therapy Methods · doi:10.1089/hgtb.2019.276 · Cited by 59
Recombinant Adeno-Associated Viral Vector Production and Purification
Shin, J., Yue, Y., & Duan, D. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-343-1_15 · Cited by 54
A bistable inhibitory optoGPCR for multiplexed optogenetic control of neural circuits
Wietek, J., Nozownik, A., Pulin, M., Saraf‐Sinik, I., Matosevich, N., Gowrishankar, R., Gat, A., Malan, D., Brown, B. J., Dine, J., et al. (2024) · Nature Methods · doi:10.1038/s41592-024-02285-8 · Cited by 52
Rational engineering of a functional CpG-free ITR for AAV gene therapy
Pan, X., Yue, Y., Boftsi, M., Wasala, L. P., Tran, N. T., Zhang, K., Pintel, D. J., Tai, P. W. L., & Duan, D. (2022) · Gene Therapy · doi:10.1038/s41434-021-00296-0 · Cited by 53
Gene therapy in animal models of autosomal dominant retinitis pigmentosa.
Rossmiller, B. P., Mao, H., & Lewin, A. S. (2012) · PubMed · Cited by 52
Viral Vectors: A Wide Range of Choices and High Levels of Service
Osten, P., Grinevich, V., & Cetin, A. H. (2007) · Springer eBooks · doi:10.1007/978-3-540-35109-2_8 · Cited by 54
Prasad, K.-M. R., SMITH, R. S., Xu, Y., & French, B. A. (2011) · The Journal of Gene Medicine · doi:10.1002/jgm.1576 · Cited by 52
Zhen, Z., Espinoza, Y., Bleu, T., Sommer, J. M., & Wright, J. F. (2004) · Human Gene Therapy · doi:10.1089/1043034041361262 · Cited by 51
Gene-based antiangiogenic applications for corneal neovascularization
Liu, S., Romano, V., Steger, B., Kaye, S. B., Hamill, K. J., & Willoughby, C. E. (2017) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2017.10.006 · Cited by 53
Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids
Mietzsch, M., Eddington, C., Jose, A., Hsi, J., Chipman, P. R., Henley, T., Choudhry, M. S., McKENNA, R. V., & Agbandje‐McKenna, M. (2021) · Journal of Virology · doi:10.1128/jvi.00773-21 · Cited by 53
Löw, K., Aebischer, P., & Schneider, B. L. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.174 · Cited by 53
Bcl-xL Is Necessary for Neurite Outgrowth in Hippocampal Neurons
Park, H., Licznerski, P., Alavian, K. N., Shanabrough, M., & Jonas, E. A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5570 · Cited by 48
Aschauer, D. F., Eppler, J.-B., Ewig, L., Chambers, A. R., Pokorny, C., Kaschube, M., & Rumpel, S. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110340 · Cited by 55
FGF22 signaling regulates synapse formation during post‐injury remodeling of the spinal cord
Jacobi, A., Loy, K., Schmalz, A., Hellsten, M., Umemori, H., Kerschensteiner, M., & Bareyre, F. M. (2015) · The EMBO Journal · doi:10.15252/embj.201490578 · Cited by 49
Gene therapy methods in bone and joint disorders
Ulrich‐Vinther, M. (2007) · Acta Orthopaedica · doi:10.1080/17453690610046512 · Cited by 47
A universal system to select gene-modified hepatocytes in vivo
Nygaard, S. C., Barzel, A., Haft, A., Major, A. M., Finegold, M. J., Kay, M. A., & Grompe, M. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad8166 · Cited by 47
Self-citationEffects of Sustained Antiangiogenic Therapy in Multistage Prostate Cancer in TRAMP Model
Isayeva, T., Chanda, D., Kallman, L., Eltoum, I. A., & Ponnazhagan, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3637 · Cited by 47
Nieto, K., Stahl-Hennig, C., Leuchs, B., Müller, M., Gissmann, L., & Kleinschmidt, J. A. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.202 · Cited by 46
Self-citationDual lipidation of the brain-specific Cdc42 isoform regulates its functional properties
Wirth, A., Chen, C., Wu, Y., Gorinski, N., Filippov, M. A., Pandey, G. N., & Ponimaskin, E. G. (2013) · Biochemical Journal · doi:10.1042/bj20130788 · Cited by 46
Kommaddi, R. P., Tomar, D. S., Karunakaran, S., Bapat, D., Nanguneri, S., Ray, A., Schneider, B. L., Nair, D. K., & Ravindranath, V. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7754 · Cited by 44
Differential myofiber-type transduction preference of adeno-associated virus serotypes 6 and 9
Riaz, M., Raz, Y., Moloney, E. B., van Putten, M., Krom, Y. D., van der Maarel, S. M., Verhaagen, J., & Raz, V. (2015) · Skeletal Muscle · doi:10.1186/s13395-015-0064-4 · Cited by 42
Seno, M. M. G., Graham, I. R., Athanasopoulos, T., Trollet, C., Pohlschmidt, M., Crompton, M. R., & Dickson, G. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn162 · Cited by 44
Collins, L. T., Ponnazhagan, S., & Curiel, D. T. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00589 · Cited by 44
Genome-wide RNAi screening identifies host restriction factors critical for in vivo AAV transduction
Mano, M., Ippodrino, R., Zentilin, L., Zacchigna, S., & Giacca, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503607112 · Cited by 39
Therapeutic Strategies for the Inherited Neuropathies
Shy, M. E. (2006) · NeuroMolecular Medicine · doi:10.1385/nmm:8:1-2:255 · Cited by 39
Tas, S. W., Adriaansen, J., Hajji, N., Bakker, A. C., Firestein, G. S., Vervoordeldonk, M. J., & Tak, P. P. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.821 · Cited by 41
DNA Minicircle Technology Improves Purity of Adeno-associated Viral Vector Preparations
Schnödt, M., Schmeer, M., Kracher, B., Krüsemann, C., Espinosa, L. E., Grünert, A., Fuchsluger, T., Rischmüller, A., Schleef, M., & Büning, H. (2016) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2016.60 · Cited by 39
Link, N., Brunner, T. J., Dreesen, I. A. J., Stark, W. J., & Fussenegger, M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21525 · Cited by 38
Sadleir, K. R., Eimer, W. A., Kaufman, R. J., Osten, P., & Vassar, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101643 · Cited by 40
Kou, J., Kim, H.-D., Pattanayak, A., Song, M., Lim, J.-E., Taguchi, H., Paul, S., Cirrito, J. R., Ponnazhagan, S., & Fukuchi, K.-I. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110230 · Cited by 37
Hadaczek, P., Stanek, L. M., Ciesielska, A., Sudhakar, V. R., Samaranch, L., Pivirotto, P., Bringas, J., O’Riordan, C. R., Mastis, B., Sebastián, W. S., et al. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.37 · Cited by 37
A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors
Qizhao, W., Wu, Z., Zhang, J., Firrman, J., Wei, H., Zhuang, Z., Liu, L., Miao, L., Hu, Y., Li, D., et al. (2017) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.002 · Cited by 37
Yan, Z., Lei-Butters, D. C. M., Keiser, N. W., & Engelhardt, J. F. (2012) · Gene Therapy · doi:10.1038/gt.2012.46 · Cited by 33
Heterotopic Transcallosal Projections Are Present throughout the Mouse Cortex
Chovsepian, A., Empl, L., Correa, D., & Bareyre, F. M. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00036 · Cited by 36
Mietzsch, M., Hering, H., Hammer, E.-M., Agbandje‐McKenna, M., Zolotukhin, S., & Heilbronn, R. (2017) · Human Gene Therapy Methods · doi:10.1089/hgtb.2016.164 · Cited by 35
Arnett, A. L. H., Beutler, L. R., Quintana, A., Allen, J. M., Finn, E. E., Palmiter, R. D., & Chamberlain, J. S. (2012) · Gene Therapy · doi:10.1038/gt.2012.60 · Cited by 34
Brain endothelial specific gene therapy improves experimental Sandhoff disease
Dogbevia, G., Graßhoff, H., Othman, A., Penno, A., & Schwaninger, M. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19865917 · Cited by 34
Sanz‐Morello, B., Pfisterer, U., Hansen, N. W., Demharter, S., Thakur, A., Fujii, K., Левицкий, С. А., Montalant, A., Korshunova, I., Mammen, P. P. A., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020105759 · Cited by 33
Gong, Y., Chang, Z.-P., Ren, R., Wei, S., Zhou, H., Chen, X., Hou, B., Jin, X., & Zhang, M.-N. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9779-x · Cited by 35
Leriche, L., Björklund, T., Breysse, N., Besret, L., Grégoire, M., Carlsson, T., Dollé, F., Mandel, R. J., Déglon, N., Hantraye, P., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4491-08.2009 · Cited by 33
Su, W., Kang, J., Sopher, B. L., Gillespie, J., Aloi, M. S., Odom, G. L., Hopkins, S., Case, A., Wang, D. B., Chamberlain, J. S., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13081 · Cited by 37
Melanocortin receptor-mediated effects on obesity are distributed over specific hypothalamic regions
de Backer, M. W. A., la Fleur, S. E., Brans, M. A. D., van Rozen, A. J., Luijendijk, M. C. M., Merkestein, M., Garner, K. M., van der Zwaal, E. M., & Adan, R. A. H. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.169 · Cited by 33
Vliet, K. V., Mohiuddin, Y., McClung, S. H., Blouin, V., Rolling, F., Moullier, P., Agbandje‐McKenna, M., & Snyder, R. O. (2009) · Journal of Virological Methods · doi:10.1016/j.jviromet.2009.03.020 · Cited by 33
Jethwa, P. H., Warner, A., Fowler, M. J., Murphy, M., de Backer, M. W. A., Adan, R. A. H., Barrett, P., Brameld, J. M., & Ebling, F. J. P. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02001.x · Cited by 32
Reducing the Risk of Adeno-Associated Virus (AAV) Vector Mobilization with AAV Type 5 Vectors
Hewitt, F. C., Li, C., Gray, S. J., Cockrell, S. K., Washburn, M. L., & Samulski, R. J. (2009) · Journal of Virology · doi:10.1128/jvi.02466-08 · Cited by 30
NPY Y2 receptors in the central amygdala reduce cued but not contextual fear
Verma, D., Wood, J. C., Lach, G., Mietzsch, M., Weger, S., Heilbronn, R., Herzog, H., Bonaventure, P., Sperk, G., & Tasan, R. O. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.038 · Cited by 35
Optimization of Adeno-Associated Viral Vector-Mediated Gene Delivery to the Hypothalamus
de Backer, M. W. A., Brans, M. A. D., Luijendijk, M. C. M., Garner, K. M., & Adan, R. A. H. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.169 · Cited by 29
Proteolytic Mapping of the Adeno-associated Virus Capsid
Vliet, K. V., Blouin, V., Agbandje‐McKenna, M., & Snyder, R. O. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.08.1222 · Cited by 32
Ilchibaeva, T. V., Tsybko, A. S., Lipnitskaya, M., Eremin, D. V., Milutinovich, K. S., Naumenko, V. S., & Popova, N. K. (2023) · Biomedicines · doi:10.3390/biomedicines11051482 · Cited by 30
Hoyng, S. A., de Winter, F., Gnavi, S., van Egmond, L., Attwell, C. L., Tannemaat, M. R., Verhaagen, J., & Malessy, M. J. A. (2015) · Gene Therapy · doi:10.1038/gt.2015.47 · Cited by 28
Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus
Tang, Q., Keeler, A. M., Zhang, S., Su, Q., Lyu, Z., Cheng, Y., Gao, G., & Flotte, T. R. (2020) · BioResearch open access · doi:10.1089/biores.2020.0031 · Cited by 29
Fakhiri, J., & Grimm, D. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.005 · Cited by 29
Self-citationSchwenger, D. B., & Kuner, T. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07391.x · Cited by 29
Gene therapy decreases seizures in a model of Incontinentia pigmenti
Dogbevia, G., Töllner, K., Körbelin, J., Bröer, S., Ridder, D. A., Graßhoff, H., Brandt, C., Wenzel, J., Straub, B. K., Trepel, M., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24981 · Cited by 30
A stable sensory map emerges from a dynamic equilibrium of neurons with unstable tuning properties
Chambers, A. R., Aschauer, D. F., Eppler, J.-B., Kaschube, M., & Rumpel, S. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac445 · Cited by 32
Printz, Y., Patil, P., Mahn, M., Benjamin, A., Litvin, A., Levy, R., Bringmann, M., & Yizhar, O. (2023) · Nature Communications · doi:10.1038/s41467-023-37318-x · Cited by 30
A New Method for Recombinant Adeno-associated Virus Vector Delivery to Murine Diaphragm
Mah, C. S., Fraites, T. J., Cresawn, K. O., Zolotukhin, I., Lewis, M. A., & Byrne, B. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.01.006 · Cited by 28
Regulation of Episomal Gene Expression by KRAB/KAP1-Mediated Histone Modifications
Barde, I., Laurenti, E., Verp, S., Groner, A. C., Towne, C. L., Padrun, V., Aebischer, P., Trumpp, A., & Trono, D. (2009) · Journal of Virology · doi:10.1128/jvi.00001-09 · Cited by 28
Veldwijk, M. R., Sellner, L., Stiefelhagen, M., Kleinschmidt, J. A., Laufs, S., Topaly, J., Früehauf, S., Zeller, W. J., & Wenz, F. K. (2009) · Cytotherapy · doi:10.3109/14653240903348293 · Cited by 27
Self-citationvan Lieshout, L. P., Rubin, M., Costa-Grant, K., Ota, S., Golebiowski, D., Panico, T., Wiberg, E., Szymczak, K., Gilmore, R., Stanvick, M., et al. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.05.004 · Cited by 28
Production and Purification of Recombinant Adeno-Associated Vectors
Wang, L., Blouin, V., Brument, N., Bello-Roufaı̈, M., & François, A. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-370-7_16 · Cited by 26
AAV6 Vector Production and Purification for Muscle Gene Therapy
Halbert, C. L., Allen, J. M., & Chamberlain, J. S. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7374-3_18 · Cited by 26
Verhaagen, J., Hobo, B., Ehlert, E., Eggers, R., Korecka, J. A., Hoyng, S. A., Attwell, C. L., Harvey, A. R., & Mason, M. R. J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7522-8_1 · Cited by 26
Gene Delivery to Adipose Tissue Using Transcriptionally Targeted rAAV8 Vectors
Uhrig-Schmidt, S., Geiger, M., Luippold, G., Birk, G., Mennerich, D., Neubauer, H., Grimm, D., Wolfrum, C., & Kreuz, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116288 · Cited by 26
Self-citationKoch (2014) · doi:10.1074/jbc.m113.504860 · Cited by 25
Negrete, A., & Kotin, R. M. (2008) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/eln034 · Cited by 24
Synapse maintenance and restoration in the retina by NGL2
Soto, F., Zhao, L., & Kerschensteiner, D. (2018) · eLife · doi:10.7554/elife.30388 · Cited by 25
Gene delivery to the vasculature mediated by low‐titre adeno‐associated virus serotypes 1 and 5
Sen, S., Conroy, S., Hynes, S. O., McMahon, J. M., O'Doherty, A., Bartlett, J. S., Akhtar, Y., Adegbola, T., Connolly, C. E., Sultan, S., et al. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1133 · Cited by 25
Tmem65 is critical for the structure and function of the intercalated discs in mouse hearts
Teng, A. C. T., Gu, L., Paola, M. D., Lakin, R., Williams, Z. J., Au, A., Chen, W., Callaghan, N. I., Zadeh, F. H., Zhou, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33303-y · Cited by 25
Naumer, M., Ying, Y., Michelfelder, S., Reuter, A., Trepel, M., Müller, O. J., & Kleinschmidt, J. A. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.139 · Cited by 24
Self-citationComparison of Viral and Nonviral Vectors for Gene Transfer to Human Endothelial Progenitor Cells
Kealy, B., Liew, A., McMahon, J. M., Ritter, T., O’Doherty, A., Hoare, M., Greiser, U., Vaughan, E. E., Maenz, M., O'Shea, C. A., et al. (2009) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2008.0323 · Cited by 24
Berraondo, P., Scala, M. D., Korolowicz, K. E., Thampi, L. M., Otano, I., Suárez-Amarán, L., Fioravanti, J., Aranda, F., Ardaiz, N., Yang, J., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.048 · Cited by 24
Gene Therapy for Cystic Fibrosis Airway Disease- Is Clinical Success Imminent?
Anson, D. S., Smith, G., & Parsons, D. (2006) · Current Gene Therapy · doi:10.2174/156652306776359496 · Cited by 24
Vrouwe, J. P. M., Meulenberg, J. J. M., Klarenbeek, N. B., Navas-Cañete, A., Reijnierse, M., Ruiterkamp, G., Bevaart, L., Lamers, R. J., Kloppenburg, M., Nelissen, R. G. H. H., et al. (2021) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2021.09.013 · Cited by 25
Pinto, C., Silva, G. P. D. L., Ribeiro, A. S., Oliveira, M., Garrido, M., Bandeira, V., Nascimento, A., Coroadinha, A. S., Peixoto, C., Barbas, A., et al. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.05.016 · Cited by 23
Kou, J., Yang, J., Lim, J.-E., Pattanayak, A., Song, M., Planque, S. A., Paul, S., & Fukuchi, K.-I. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8691-z · Cited by 22
Kondaurova, E. M., Belokopytova, I. I., Kulikova, E. A., Хоцкин, Н. В., Ilchibaeva, T. V., Tsybko, A. S., Popova, N. K., & Naumenko, V. S. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114168 · Cited by 21
Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 Splicing
Odermatt, P., TRUEB, J., Furrer, L., Fricker, R., Marti, A., & Schümperli, D. (2016) · Molecular Therapy · doi:10.1038/mt.2016.152 · Cited by 23
Metadata
- Authors
- Grimm, D., Kay, M. A., & Kleinschmidt, J. A.
- Affiliations
- Stanford Medicine (US)
- German Cancer Research Center (DE)
- Corresponding author
- Kay, Mark A
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 7
- Issue
- 6
- Pages
- 839-850
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W1977797303
- Cited by
- 344
- References
- 36
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 12 · 2023: 10 · 2022: 15 · 2021: 17 · 2020: 12 · 2019: 18 · 2018: 5 · 2017: 17 · 2016: 7 · 2015: 21 · 2014: 12 · 2013: 20 · 2012: 19
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Therapy (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL66948, U01HL066948)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Keywords
- adeno-associated virus vectors, fluorescent protein markers, cell tropism, transgene expression kinetics, gene therapy vectors
- MeSH terms
- Dependovirus, Cell Line, DNA Replication, DNA-Binding Proteins, Genetic Vectors, Helper Viruses, Humans, Plasmids, Serotyping, Viral Proteins, Virus Replication, Virus Assembly
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review